CLL-1 CAR-T
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CLL-1 CAR-T, covering 2026-01-13 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia [NA]